RUC and the ridiculous RVU for certain procedures and the overuse of those procedures is a different issue. Creating a different issue where oncology is in bed with pharma directly as part of routine and nth line chemo is the norm for drugs that have to show the lowest version of clinical efficacy of any class on the market for approval is an entirely different problem. Both of them are wrong but one doesn't make the other right. If my orthopod was selling me the implant they planned to put in my body I would have huge ethical concerns over that practice, wouldn't you?.